Andersons (ANDE) Amended Form 4 Shows Dividend Reinvestment for Director
Rhea-AI Filing Summary
Insider transaction summary for Andersons, Inc. (ANDE) Ross W. Manire, a company director, reported an amended Form 4 showing a non‑derivative acquisition on 05/09/2025. The filing states shares were received in lieu of a cash dividend (noted in the explanation). The reported transaction line shows an acquisition of 9.65 shares at a price of $0, and total beneficial ownership following the transaction of 33,567.182 shares held directly. The form indicates it is an amendment and includes a signature block executed under a limited power of attorney.
Positive
- Shares received in lieu of cash dividend are clearly disclosed
- Total direct beneficial ownership after the transaction is provided (33,567.182 shares)
- Amendment and power of attorney are documented, improving disclosure completeness
Negative
- None.
Insights
TL;DR: Routine dividend reinvestment increased a director's direct holdings modestly; no cash paid for the shares.
The filing documents a non‑derivative acquisition where shares were issued in lieu of a cash dividend, increasing the reporting person’s direct beneficial ownership to 33,567.182 shares. The acquisition quantity shown is 9.65 shares at a reported price of $0, consistent with dividend‑in‑kind treatment. This disclosure is informational and does not indicate additional compensation or option activity.
TL;DR: Amended Form 4 properly discloses a dividend reinvestment; signature via limited power of attorney is documented.
The report is marked as an amendment and includes an explanatory remark that the shares were issued in lieu of a cash dividend. The signature area shows the form was signed by Melissa Trippel under a limited power of attorney for Ross W. Manire, which is a standard practice for filings when the reporting person delegates execution. No indication of unusual or compensatory transactions is present in the filing text.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9.65 | $0.00 | -- |
Footnotes (1)
- [object Object]